The 3rd Next Generation Lipid-Based Nanoparticle Delivery Summit returned in 2024 as our partner's definitive industry summit for lipid-based nanoparticle experts looking to unlock to therapeutic power of this promising vehicle through cutting-edge delivery innovations.

Through our extensive research with the industry, we knew our audience were seeking expertise with lipid tissue tropism, active targeting, off-target effects to maximize therapeutic efficacy for repeat therapeutic administration.

As a solution provider in this space, our partners were offered a unique opportunity to address critical needs in LNP delivery. Our platform supported our partners in showcasing their expertise in lipid development, where they could engage with key stakeholders dedicated to advancing LNPs for safe and efficacious drug delivery.

With the inclusion of preclinical model providers, the focus on dosing and translatability intensifies. Networking with these experts facilitates the exploration of outsourcing options for clinically relevant models, whether in vitro or in vivo.

Join us next time as a partner, to collaborate and drive innovation in drug delivery solutions, ensuring a transformative impact on patient care and solidifying your position at the forefront of the industry's most ground-breaking advancements.